openPR Logo
Press release

Stent-Assisted Coiling Market to show significant growth rate through 2031

03-16-2021 08:56 AM CET | Health & Medicine

Press release from: Fact.MR

Stent-assisted coiling is a safe, effective and durable treatment for aneurysm closure. The stent-assisted coiling marketplace continues to remain under the influence of clinical clearance, success rates and market sustenance. As neurovascular stents for stent-assisted coiling (SAC) provide important options for wide-neck brain aneurysm treatment, the technology incorporated continues to evolve in a bid to address associated risks. While the stent-assisted coiling market has the presence of different type of stents, reports regarding periprocedural stroke and death while using the stent-assisted coiling related to poor patient selection or procedural risks.

This Press Release will help you to understand the market Statistics of European Region.

Click HERE To get SAMPLE PDF (Including Full TOC, Table & Figures) at @ https://www.factmr.com/connectus/sample?flag=S&rep_id=1135

Advancement in endovascular operative techniques has facilitated treatment of wide range of intracranial aneurysms. Stent-assisted coiling is one of the minimally invasive technique in the treatment of a wide-necked intracranial aneurysm. Stents are used as scaffolds to assist coil embolization in stent-assisted coiling procedures. Stent-assisted coiling involves placing a stent inside of wide neck aneurysm to fix coil that protects damaged blood vessel walls. Nowadays, Stent-assisted coiling can be highly performed procedure for the ruptured aneurysm. However, the stent-assisted coiling diminishes the risk of stent-associated thromboembolic complications, antiplatelet therapy. Many healthcare practitioners considered stent-assisted technique as renderings technique for exposing of elevated risk of bleeding related complication if any complex surgery is consequently required. According to brain aneurysm foundation, 6 million people in the U.S. have the unruptured brain aneurysm or about 30,000 people suffer from brain aneurysm rupture.

Stent-Assisted Coiling Market: Drivers and Restraints-

Increasing prevalence of an aneurysm and intracranial disorder the major factors which expected to drive stent-assisted coiling market. Technology advancement, improvement in healthcare facilities, adoption of new surgical options are expected to boost the global stent-assisted coiling market. Adoption stent-assisted coiling over coiling, raising awareness, improvement in reimbursement scenario is driving the stent-assisted coiling market. The stent-assisted coiling market is expected to show significant growth rate in forecast period due to increasing government initiatives and adoption of minimally invasive surgical procedures. However, factor such as high cost of surgical procedures, complex surgery, and lack of skilled or experienced professionals for performing surgery is restraining the growth of the global stent-assisted coiling market.

To receive extensive list of important regions, ask for TOC here@ https://www.factmr.com/connectus/sample?flag=T&rep_id=1135

Stent-Assisted Coiling Market: Segmentation

On the basis of product type, stent-assisted coiling market can be segmented as:
• Self-Expandable Stents
• Liquid Embolic Devices
• Flow-diversion devices
• Embolic Coils

On the basis of the end user, the cardiac mapping system market can be segmented as:
• Hospitals
• Clinics
• Ambulatory Surgical Centers

Stent-Assisted Coiling Market: Overview

An aneurysm is a complex intracranial endovascular disease. A brain aneurysm is the reason of 5,00,000 deaths each year worldwide and half of the sufferer are younger than 50. Stent-assisted coiling is the much less invasive procedure to repair the ruptured aneurysm. Two main self-expandable stents, Neuroform and enterprise stent are usually used for stent-assisted coiling of complex intracranial aneurysms. Stent assisting coiling to ease the endovascular treatment of a wide-neck intracranial aneurysm. Introduction of new surgical procedures techniques, increasing adoption of minimally invasive surgeries, increasing healthcare expenditures are expected to boost the stent-assisted coiling market.

Pre-Book Right Now for Exclusive Analyst Support @ https://www.factmr.com/checkout/1135/S

Stent-Assisted Coiling Market: Key Market Participants

Example of some key market participants in global stent-assisted coiling market identify across the value chain are DePuy Synthes, Medtronic Plc, MicroPort Scientific Corporation, Stryker Corporation, OBEX Medical Limited. Some of the other companies having the significant presence in the global stent-assisted coiling market are Abbott Laboratories, ADMEDES GmbH, Balt Extrusion, Cardiatis and Penumbra, Inc. Global market players are introducing new products with better efficiency to create good market opportunities for the stent-assisted coiling market. Rising number of mergers and acquisitions, increasing number of collaborations and partnerships are key trends that are observed in the global stent-assisted coiling market.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com
Research Insight: https://www.factmr.com/report/1135/stent-assisted-coiling-market

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Stent-Assisted Coiling Market to show significant growth rate through 2031 here

News-ID: 2256863 • Views:

More Releases from Fact.MR

Dry Eye Syndrome Treatment Market is Estimatd to Reach USD 11.0 Billion by 2034 | Fact.MR Report
08-28-2025 | Health & Medicine
Fact.MR
Dry Eye Syndrome Treatment Market is Estimatd to Reach USD 11.0 Billion by 2034 …
Fact.MR today released its latest report on the Dry Eye Syndrome Treatment Market, projecting robust growth driven by rising prevalence of dry eye syndrome, increasing screen time, and advancements in treatment options. Valued at USD 4.0 billion in 2024, the global market is forecast to expand at a compound annual growth rate (CAGR) of 7.2%, reaching USD 11.0 billion by 2034. This significant growth underscores the growing demand for effective
Scar Treatment Market to Reach USD 18.6 Billion by 2034 | Fact.MR
08-28-2025 | Health & Medicine
Fact.MR
Scar Treatment Market to Reach USD 18.6 Billion by 2034 | Fact.MR
Fact.MR today released its latest report on the Scar Treatment Market, forecasting steady growth driven by rising consumer focus on aesthetic appearance, advancements in dermatological technologies, and increasing demand for minimally invasive procedures. Valued at USD 12.6 billion in 2024, the global market is projected to expand at a compound annual growth rate (CAGR) of 4.0%, reaching USD 18.6 billion by 2034. This growth highlights the increasing importance of scar
Acne Treatment Market is Projected to Reach USD 12.44 Billion by 2034 | Fact.MR
08-28-2025 | Health & Medicine
Fact.MR
Acne Treatment Market is Projected to Reach USD 12.44 Billion by 2034 | Fact.MR
The global acne treatment market is estimated at USD 7.2 billion in 2024 and is forecasted to reach USD 12.44 billion by 2034, advancing at a compound annual growth rate (CAGR) of 5.6%. This steady expansion is driven by the increasing prevalence of acne across diverse demographics, influenced by factors such as diet, stress, hormonal imbalances, and environmental conditions. The market's growth reflects a shift toward personalized and innovative treatments,
Point of Sale (POS) Terminal Market is Projected to Reach USD 195.8 Billion by 2034 | Fact.MR
Point of Sale (POS) Terminal Market is Projected to Reach USD 195.8 Billion by 2 …
Expanding at a CAGR of 7.2%, the global point of sale (POS) terminal market is projected to reach USD 195.8 billion by the end of 2034, increasing from USD 97.7 billion in 2024. This growth is driven by the increasing adoption of digital payment tools, the implementation of 5G for high-speed connectivity, and the digital transformation across industries such as retail, healthcare, and hospitality. POS terminals enhance transaction accuracy, reduce

All 5 Releases


More Releases for Stent

Airway Stent Lung Stent Market Size 2024 to 2031.
Market Overview and Report Coverage An airway stent, also known as a lung stent, is a medical device used to open up blocked airways in the lungs. It is typically used in patients with conditions such as tracheal or bronchial stenosis, tumors, or strictures. The global airway stent lung stent market is expected to grow at a CAGR of 6.10% during the forecasted period. The future outlook for the airway stent lung
Airway Stent and Lung Stent Market Revenue Surges: Acumen Research Projection
The airway stent/lung stent market is witnessing a significant surge in revenue, projected to increase by USD 204.4 million by 2032. This growth is driven by a Compound Annual Growth Rate (CAGR) of 6.3% from 2023 to 2032. This article delves into the various facets of the market, including regional dominance, segment growth, and the underlying factors fueling this expansion. Market Revenue Growth The global airway stent/lung stent market is on an
Gel Stent Market Will Generate Booming Growth Opportunities to 2032 | Clinical P …
The latest Global Gel Stent Market research report 2022 provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth during the upcoming years. The Gel Stent market report also covers the size, share, potential growth, and industry strategy followed by prominent players. This report also includes profiles for major companies within the market. There is wide acceptance of Gel Stent across the buyers' segments and this has been driving the
Gel Stent Market To Offer Lucrative Growth Opportunities to 2032 | Clinical Phas …
The global Gel Stent market research report offers domain wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. The wide application portfolio of Gel Stent is one of factors driving the growth of domain worldwide. The global market is moderately competitive with a blend of global and regional players. The industry players invest significantly in R&D to enhance their offerings. The entire
Global Evar Stent Grafts Market, Global Evar Stent Grafts Industry, Covid-19 Imp …
The aortic-aneurysm is a swelling & dilation the wall of blood-vessel, in general an artery, owing to weakness or degeneration, which develops in the segment of artery wall. Endovascular-aneurysm-repair or EVAR contains the conveying of implant in the aneurysm through small-groin incisions with X-rays to guide the graft into place. EVAR is an ideal treatment option for the aortic aneurysm considering to its advantages over the open surgery. Some of
Airway Stent/Lung Stent Market Size, Share, Trends & Forecast 2019-2025
The airway stent/lung stent market is forecast to grow at a CAGR of 5.8% attributed to the increasing adoption of bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. The airway invasion is common in the patient diagnosed with lung cancer. These patients may develop stridor, intractable cough, post obstructive, dyspnea, hemorrhage, pneumonia and intractable cough due to tracheobronchial tumor extension. The optimal management of patients